Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.
For research use only. We do not sell to patients.
Name | Roquinimex |
---|---|
Iupac Chemical Name | Roquinimex |
Synonyms | Linomide; FCF89; LS2616; ABR212616; PNU212616 |
Molecular Formula | C18H16N2O3 |
Molecular Weight | 308.33 |
Smile | Cn1c2ccccc2c(c(c1=O)C(=O)N(C)c3ccccc3)O |
InChiKey | SGOOQMRIPALTEL-UHFFFAOYSA-N |
InChi | InChI=1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3 |
CAS Number | 84088-42-6 |
MDL | MFCD00866331 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |